Take the guess work out of recruiting for cell therapy-related job openings at your company or institution.
Reach more than 11,000 potential candidates by advertising your career opportunities with Cell Therapy News.
Click here to begin recruiting today.
Sperm Cells Created from Female Embryo
British scientists who had already coaxed male bone marrow cells to develop into primitive sperm cells have now repeated the feat with female embryonic stem cells.
Flawed Embryos Seen as Source for Stem Cells
From what is now considered medical waste might be fashioned bio-treasure: stem cells able to form into any of the body’s 220 cell types, including blood, nerves, bone, and skin tissue, new research suggests.
By Modifying a Stem Cell’s Surface, Researchers Can Steer Cells Where Needed
In a groundbreaking study, Robert Sackstein, MD, PhD, and colleagues in the Department of Dermatology at the Biomedical Research Institute at Brigham and Women’s Hospital harmlessly modified the surface of human mesenchymal stem cells, which directed the cells through the bloodstream into bone, where they matured into new bone cells.
Monash Pioneers Nano Scaffold to Rebuild Nerve Damage
A Monash University PhD student has developed a new technique that could revolutionise stem cell treatment for Parkinson’s disease and spinal cord injury.
Stem Cells Treatment for Brittle Bones in the Womb
The extraordinary results of an in utero stem cell treatment could lead to a new treatment for babies with brittle bones, as well as a range of other disabling conditions, according to a maternal-fetal medicine researcher, now based at The University of Queensland.
Stem Cell Therapy Studies for Stroke, Cerebral Palsy Prepare for Clinical Trials
Finding answers about optimal dosage and timing for stem cell therapy in adults with strokes and newborns with ischemic injuries is a goal of two new federally funded studies.
Advanced Cell Technology Announces Completion of Pre-IND Meeting with the FDA for RPE Therapy for the Treatment of Retinal Degenerative Disease
Advanced Cell Technology, Inc. has announced that it completed discussions with the Food and Drug Administration regarding its retinal pigmented epithelial cell therapy through a type B, pre-Investigational New Drug meeting concerning the regulatory pathway and requirements to file an IND to initiate human clinical trials.
First Patients Treated in Cytori’s Stem & Regenerative Cell Heart Attack Study
Cytori Therapeutics enrolled the first two patients in a clinical trial using adipose-derived stem and regenerative cells in the treatment of heart attack. In this trial, patients’ cells are made available using Cytori’s Celution(TM) System, a real-time cell processing device.
Stroke Victims May Benefit from Stem Cell Transplants
According to two studies published in the current issue of CELL TRANSPLANTATION, stroke victims may benefit from human mesenchymal stem cell or bone marrow stromal cell transplantation. In both studies, the migration of chemically “tagged” transplanted stem cells were tracked to determine the degree to which the transplanted cells reached damaged areas of the brain and became therapeutically active.
Spinal Cord Stem Cell Hope
Spinal cord injury sufferers have been given fresh hope of improved movement with the first Australian trial of a new adult stem cell treatment.
Organ Transplants Without the Drugs
In an intriguing but small study published in the New England Journal of Medicine, doctors at Massachusetts General Hospital and New York Presbyterian Hospital may have finally come up with an end run around organ rejection.
Questioning the Allure of Putting Cells in the Bank
Some experts say consumers should think twice before spending hundreds or thousands of dollars on such services, because it is not clear how useful such cells will be.
ABSTRACTS, REVIEWS AND SPECIAL REPORTS
Intrauterine Transplantation of Human Fetal Mesenchymal Stem Cells from First-trimester Blood Repairs Bone and Reduces Fractures in Osteogenesis Imperfecta Mice
The researchers found that intrauterine transplantation of fetal mesenchymal stem cells markedly reduced fracture rates and skeletal abnormalities in a mouse model of the intermediate severity type III OI, suggesting a scientific basis for mesenchymal stem cells treatment of affected human fetuses.
Intravenously Administered Bone Marrow Cells Migrate to Damaged Brain Tissue and Improve Neural Function in Ischemic Rats
The researchers found that intravenously administrated bone marrow stromal cells facilitated the structural and functional recovery of neural tissue following ischemic injury, perhaps mediated by enhanced angiogenesis.
Cell Therapy Business Development Leader
Portland, OR (Invitrogen)
Irvine, CA (Global Biopharmaceutical Company)